Cargando…
Reduction in Narcotic Use After Lumbar Decompression and Fusion in Patients With Symptomatic Lumbar Stenosis or Spondylolisthesis
STUDY DESIGN: Retrospective cohort study. OBJECTIVES: The purpose of this study is to assess change in opioid use before and after lumbar decompression and fusion surgery for patients with symptomatic lumbar stenosis or spondylolisthesis. METHODS: A large insurance database was queried for patients...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693064/ https://www.ncbi.nlm.nih.gov/pubmed/31448192 http://dx.doi.org/10.1177/2192568218814235 |
_version_ | 1783443639689543680 |
---|---|
author | Adogwa, Owoicho Davison, Mark A. Vuong, Victoria D. Khalid, Syed Lilly, Daniel T. Desai, Shyam A. Moreno, Jessica Cheng, Joseph Bagley, Carlos |
author_facet | Adogwa, Owoicho Davison, Mark A. Vuong, Victoria D. Khalid, Syed Lilly, Daniel T. Desai, Shyam A. Moreno, Jessica Cheng, Joseph Bagley, Carlos |
author_sort | Adogwa, Owoicho |
collection | PubMed |
description | STUDY DESIGN: Retrospective cohort study. OBJECTIVES: The purpose of this study is to assess change in opioid use before and after lumbar decompression and fusion surgery for patients with symptomatic lumbar stenosis or spondylolisthesis. METHODS: A large insurance database was queried for patients with symptomatic lumbar stenosis or spondylolisthesis undergoing index lumbar decompression and fusion procedures between 2007 and 2016. This database consists of 20.9 million covered lives and includes private/commercially insured and Medicare Advantage beneficiaries. Opioid use 6 months preoperatively through 2 years postoperatively was assessed. RESULTS: The study included 13 257 patients that underwent 1-, 2-, or 3-level posterior lumbar instrumented fusion. Overall, 57.8% of patients used opioids preoperatively. Throughout the 6-month preoperative period, 2 368 008 opioid pills were billed for (51.6 opioid pills/opioid user/month). When compared with preoperative opioid use, patients billed fewer opioid medications in the 2-year period postoperatively: 33.6 pills/patient/month (8 851 616 total pills). In a multivariate logistic regression analysis, obesity (odds ratio [OR] 1.10, 95% CI 1.004-1.212), preoperative narcotic use (OR 3.43, 95% CI 3.179-3.708), length of hospital stay (OR 1.02, 95% CI 1.010-1.021), and receiving treatment in the South (OR 1.18, 95% CI 1.074-1.287) or West (OR 1.26, 95% CI 1.095-1.452) were independently associated with prolonged postoperative (>1 year) opioid use. Additionally, males (OR 0.87, 95% CI 0.808-0.945) were less likely to use long-term opioid therapy. CONCLUSIONS: This study demonstrates that reduction in opioid use was observed postoperatively in comparison with preoperative values in patients with symptomatic lumbar stenosis or spondylolisthesis that underwent lumbar decompression with fusion. Further prospective studies that are more methodologically stringent are needed to corroborate our findings. |
format | Online Article Text |
id | pubmed-6693064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-66930642019-08-23 Reduction in Narcotic Use After Lumbar Decompression and Fusion in Patients With Symptomatic Lumbar Stenosis or Spondylolisthesis Adogwa, Owoicho Davison, Mark A. Vuong, Victoria D. Khalid, Syed Lilly, Daniel T. Desai, Shyam A. Moreno, Jessica Cheng, Joseph Bagley, Carlos Global Spine J Original Articles STUDY DESIGN: Retrospective cohort study. OBJECTIVES: The purpose of this study is to assess change in opioid use before and after lumbar decompression and fusion surgery for patients with symptomatic lumbar stenosis or spondylolisthesis. METHODS: A large insurance database was queried for patients with symptomatic lumbar stenosis or spondylolisthesis undergoing index lumbar decompression and fusion procedures between 2007 and 2016. This database consists of 20.9 million covered lives and includes private/commercially insured and Medicare Advantage beneficiaries. Opioid use 6 months preoperatively through 2 years postoperatively was assessed. RESULTS: The study included 13 257 patients that underwent 1-, 2-, or 3-level posterior lumbar instrumented fusion. Overall, 57.8% of patients used opioids preoperatively. Throughout the 6-month preoperative period, 2 368 008 opioid pills were billed for (51.6 opioid pills/opioid user/month). When compared with preoperative opioid use, patients billed fewer opioid medications in the 2-year period postoperatively: 33.6 pills/patient/month (8 851 616 total pills). In a multivariate logistic regression analysis, obesity (odds ratio [OR] 1.10, 95% CI 1.004-1.212), preoperative narcotic use (OR 3.43, 95% CI 3.179-3.708), length of hospital stay (OR 1.02, 95% CI 1.010-1.021), and receiving treatment in the South (OR 1.18, 95% CI 1.074-1.287) or West (OR 1.26, 95% CI 1.095-1.452) were independently associated with prolonged postoperative (>1 year) opioid use. Additionally, males (OR 0.87, 95% CI 0.808-0.945) were less likely to use long-term opioid therapy. CONCLUSIONS: This study demonstrates that reduction in opioid use was observed postoperatively in comparison with preoperative values in patients with symptomatic lumbar stenosis or spondylolisthesis that underwent lumbar decompression with fusion. Further prospective studies that are more methodologically stringent are needed to corroborate our findings. SAGE Publications 2018-11-27 2019-09 /pmc/articles/PMC6693064/ /pubmed/31448192 http://dx.doi.org/10.1177/2192568218814235 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (http://www.creativecommons.org/licenses/by-nc-nd/4.0/) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Articles Adogwa, Owoicho Davison, Mark A. Vuong, Victoria D. Khalid, Syed Lilly, Daniel T. Desai, Shyam A. Moreno, Jessica Cheng, Joseph Bagley, Carlos Reduction in Narcotic Use After Lumbar Decompression and Fusion in Patients With Symptomatic Lumbar Stenosis or Spondylolisthesis |
title | Reduction in Narcotic Use After Lumbar Decompression and Fusion in Patients
With Symptomatic Lumbar Stenosis or Spondylolisthesis |
title_full | Reduction in Narcotic Use After Lumbar Decompression and Fusion in Patients
With Symptomatic Lumbar Stenosis or Spondylolisthesis |
title_fullStr | Reduction in Narcotic Use After Lumbar Decompression and Fusion in Patients
With Symptomatic Lumbar Stenosis or Spondylolisthesis |
title_full_unstemmed | Reduction in Narcotic Use After Lumbar Decompression and Fusion in Patients
With Symptomatic Lumbar Stenosis or Spondylolisthesis |
title_short | Reduction in Narcotic Use After Lumbar Decompression and Fusion in Patients
With Symptomatic Lumbar Stenosis or Spondylolisthesis |
title_sort | reduction in narcotic use after lumbar decompression and fusion in patients
with symptomatic lumbar stenosis or spondylolisthesis |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693064/ https://www.ncbi.nlm.nih.gov/pubmed/31448192 http://dx.doi.org/10.1177/2192568218814235 |
work_keys_str_mv | AT adogwaowoicho reductioninnarcoticuseafterlumbardecompressionandfusioninpatientswithsymptomaticlumbarstenosisorspondylolisthesis AT davisonmarka reductioninnarcoticuseafterlumbardecompressionandfusioninpatientswithsymptomaticlumbarstenosisorspondylolisthesis AT vuongvictoriad reductioninnarcoticuseafterlumbardecompressionandfusioninpatientswithsymptomaticlumbarstenosisorspondylolisthesis AT khalidsyed reductioninnarcoticuseafterlumbardecompressionandfusioninpatientswithsymptomaticlumbarstenosisorspondylolisthesis AT lillydanielt reductioninnarcoticuseafterlumbardecompressionandfusioninpatientswithsymptomaticlumbarstenosisorspondylolisthesis AT desaishyama reductioninnarcoticuseafterlumbardecompressionandfusioninpatientswithsymptomaticlumbarstenosisorspondylolisthesis AT morenojessica reductioninnarcoticuseafterlumbardecompressionandfusioninpatientswithsymptomaticlumbarstenosisorspondylolisthesis AT chengjoseph reductioninnarcoticuseafterlumbardecompressionandfusioninpatientswithsymptomaticlumbarstenosisorspondylolisthesis AT bagleycarlos reductioninnarcoticuseafterlumbardecompressionandfusioninpatientswithsymptomaticlumbarstenosisorspondylolisthesis |